BioCentury
ARTICLE | Company News

China Medical gains Chinese product rights in trio of deals

August 3, 2018 5:59 PM UTC

China Medical System Holdings Ltd. (HKSE:867) announced a series of deals in July under which it gained rights to several products in China, including Hong Kong, Macao and Taiwan.

China Medical obtained exclusive rights from Venus Pharma GmbH (Werne, Germany) to develop and commercialize a portfolio of six products in China. The portfolio includes chemotherapies gemcitabine, docetaxel, pemetrexed and bortezomib, as well as carbapenem antibiotics meropenem and imipenem...